###begin article-title 0
The mechanism of complex formation between Fli-1 and SRF transcription factors
###end article-title 0
###begin p 1
###xml 243 246 <span type="species:ncbi:9606">man</span>
To whom correspondence should be addressed at present address: School of Biological Sciences, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK. Tel: +44 161 275 5979; Fax: +44 161 275 5082; Email: a.d.sharrocks@man.ac.uk
###end p 1
###begin p 2
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 924 931 924 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 176 179 <span type="species:ncbi:9860">Elk</span>
###xml 1111 1114 <span type="species:ncbi:9860">Elk</span>
The mechanisms of multicomponent transcription factor complex assembly are currently poorly defined. A paradigm for this type of complex is the ETS-domain transcription factor Elk-1 and the MADS-box transcription factor SRF which form a ternary complex with the c-fos serum response element (SRE). In this study we have analysed how a different ETS-domain transcription factor Fli-1 interacts with SRF to form ternary complexes with this element. Two regions of Fli-1 that are required for ternary complex formation have been identified. These SRF binding motifs are located on either side of the ETS DNA-binding domain. Hydrophobic amino acids within these motifs have been identified that play important roles in binding to SRF and ternary complex formation. By using Fli-1 derivatives with mutations in the N-terminal SRF binding motif, the significance of Fli-1-SRF interactions in recruitment of Fli-1 to the c-fos SRE in vivo has been demonstrated. Collectively our data provide a model of how Fli-1 interacts with SRF that differs significantly from the mechanism used by a different ETS-domain protein, Elk-1.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c1">1</xref>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c3">3</xref>
###xml 729 732 729 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c4">4</xref>
###xml 777 778 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c5">5</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 1100 1103 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1276 1277 1272 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 1382 1383 1378 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c8">8</xref>
###xml 1394 1395 1390 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 672 675 <span type="species:ncbi:9860">Elk</span>
###xml 798 801 <span type="species:ncbi:9860">Elk</span>
ETS-domain proteins comprise a large family of eukaryotic transcription factors (1-3). These proteins are grouped due to the presence of the ETS DNA-binding domain but are further subclassified due to sequence conservation within this domain and the presence of other conserved domains. The activities of many of these proteins are subject to tight regulation and respond to signal transduction cascades such as the MAP kinase pathways. Moreover, in order to elicit cell-type and promoter-specific responses, ETS-domain proteins often function in multi-component transcription factor complexes. A paradigm for this type of complex is that formed by the ETS-domain protein Elk-1 and the MADS-box transcription factor SRF at the c-fos serum response element (SRE) (reviewed in 4,5). In this complex, Elk-1 forms both protein-DNA contacts via the ETS-domain and protein-protein contacts with SRF via a short conserved motif known as the B-box (6). The B-box is located ~50 amino acids C-terminal to the ETS-domain and is necessary for binding to SRF in the absence of DNA and ternary formation at the c-fos SRE. Hydrophobic amino acids in the B-box play critical roles in binding to SRF and are thought to form the face of an alpha-helix which acts as the SRF-interaction motif (7). The reciprocal binding surface on SRF has been mapped and forms a surface-exposed hydrophobic groove (8; see Fig. 1C).
###end p 4
###begin p 5
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c9">9</xref>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EWS</italic>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli</italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c10">10</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c9">9</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c11">11</xref>
###xml 784 787 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli</italic>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c12">12</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c15">15</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c16">16</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c17">17</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c18">18</xref>
###xml 1202 1205 1202 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1210 1213 1210 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egr</italic>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 1225 1227 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c20">20</xref>
###xml 1308 1311 1308 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 145 151 <span type="species:ncbi:10090">murine</span>
###xml 182 188 <span type="species:ncbi:10090">murine</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 603 609 <span type="species:ncbi:9606">humans</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 774 783 <span type="species:ncbi:7955">zebrafish</span>
Fli-1 is a member of a different subfamily of ETS-domain transcription factors. It was originally cloned from the integration site of the Friend murine leukaemia virus (F-MuLV) in a murine erythroleukaemia cell line (9). This fusion leads to Fli-1 overexpression. Moreover, the majority of human chromosomal translocations that result in tumours related to Ewing's sarcomas involve the fusion of the EWS gene to the fli-1 gene and result in the production of proteins comprised of the N-terminal region of EWS and a variable length of the C-terminal region (containing the ETS-domain) of Fli-1 (10). In humans, Fli-1 is expressed in the heart, lung, spleen and thymus and is overexpressed in many erythroleukaemias (9,11). During early embryogenesis, the mouse, xenopus and zebrafish fli-1 genes are expressed in the haemangioblast population, endothelial cells and possibly neural crest cells (12-15). In order to elicit promoter-specific responses, Fli-1 has been shown to interact with several transcription factors including Pax-5 (16), c-Jun (17) and the ETS-domain protein Tel (18). Recently, additional complexes have been detected between Fli-1 and a EWS-Fli-1 fusion protein with SRF on the c-fos and egr-1 SREs (19,20). In comparison to wild-type Fli-1, EWS-Fli-1 forms stronger complexes on the c-fos SRE, implicating the C-terminal end of Fli-1 in binding to SRF and suggesting a role for the N-terminus of Fli-1 in inhibiting complex formation (19).
###end p 5
###begin p 6
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 378 381 <span type="species:ncbi:9860">Elk</span>
###xml 542 545 <span type="species:ncbi:9860">Elk</span>
In this study, we have investigated how Fli-1 interacts with SRF. Two SRF binding motifs (SBMs) have been mapped and are located on either side of the ETS DNA-binding domain. Subsequently, using mutational analysis the relevance of SRF binding to Fli-1 recruitment to SRF-SRE complexes in vitro and in vivo has been determined. Our results demonstrate that in comparison to the Elk-1-SRF paradigm, Fli-1 uses a novel mode of interaction with SRF, with two binding motifs, neither of which exhibit significant similarity to the SBM (B-box) of Elk-1.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Plasmid constructs
###end title 8
###begin p 9
###xml 71 88 71 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli.</italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c21">21</xref>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
The following plasmids were used for expressing GST fusion proteins in Escherichia coli. pAS58 (encoding coreSRF amino acids 132-222) (6) has been described previously. pAS818 (encoding GST-coreSRF with the point mutation T196A) was constructed by inserting a BamHI/XbaI cleaved PCR fragment (primer pair COR2/ADS569 on the template pAS430) into the same sites in pGEX-KG (21).
###end p 9
###begin p 10
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c22">22</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 717 720 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 722 725 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 925 928 925 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 930 933 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1135 1138 1135 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1140 1143 1140 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 309 312 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The following plasmids were used in mammalian cell transfections. pSRE-luc contains two copies of the c-fos SRE (nucleotides -357 to 275) upstream from a minimal tk promoter and the luciferase gene (22). pAS346 contains the E74-CAT reporter gene and has been described previously (7). pAS1005 and pAS1012 are CMV promoter-driven vectors encoding, wild type and the A224D/V225E mutant fusion proteins of full-length Fli-1 (amino acids 1-451) fused to the VP16 transcription activation domain, Fli-1[VP16] and Fli-1[VP16](A224D/V225E), respectively. pAS1005 and pAS1012 were constructed by inserting the HindIII/EcoRI fragments from pAS516 and pAS1009 into the same sites in pcDNA3. pAS513 was constructed by cloning a XhoI/XbaI cleaved PCR fragment (primer pair ADS705/ADS706, template pAS160; 15) into the same sites of pBS-SK+. pAS516 (encoding Fli-1[VP16] under the control of a T3 promoter) was constructed by ligating an NcoI/XhoI fragment from pAS513 into the same sites in pBUT2-VP16 (kindly provided by Adam Rodaway). pAS1009 (encoding Fli-1[VP16](A224D/V225E) under the control of a T3 promoter) was constructed by inserting a NcoI/XhoI cleaved PCR product (two-step PCR using the flanking primers FOR and REV, the mutagenic primer ADS659 and pAS513 as a template) into the same sites in pAS516.
###end p 10
###begin p 11
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 135 145 135 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c8">8</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c15">15</xref>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 599 602 599 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c23">23</xref>
###xml 1007 1008 1007 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 1192 1195 1192 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1201 1204 1201 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1674 1677 1674 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1683 1686 1683 1686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 168 171 <span type="species:ncbi:9860">Elk</span>
The following plasmids were used for in vitro transcription/translation. All proteins are driven by T3 promoters. pAS430 [encoding coreSRF(T196A)] (8), pAS96 (encoding Elk-1-168; amino acids 1-168) (6), pAS302, pAS303, pAS304 and pAS305 [encoding Fli-1(220-372), Fli-1(276-451), Fli-1(276-372) and Fli-1(220-451) respectively] (15) have been described previously. pAS513 (encoding full-length Fli-1, amino acids 1-451) is described above. pAS811, pAS812, pAS813 and pAS814 [encoding Fli-1(229-451), Fli-1(242-451), Fli-1(256-451) and Fli-1(266-451) respectively], were constructed by inserting NcoI-BamHI cleaved PCR products (primer pairs FOR/ADS528, FOR/ADS529, FOR/ADS530 and FOR/ADS531 on the template pAS305) into the same sites in pAS37 (23). pAS1001, pAS1002, pAS1003, pAS1004 and pAS1010 [encoding Fli-1(220-451) with the site-directed mutations Y222D, A224D, V225E, W230R and A224D/V225E respectively] were constructed using fragments obtained from a two-step PCR protocol as described previously (6) with two flanking primers FOR and REVL, the template pAS305 and the mutagenic primers ADS560, ADS561, ADS562, ADS563 and ADS650 respectively. PCR derived fragments were cleaved with NcoI and BamHI and inserted into the same sites in pAS302. pAS1013, pAS1014, pAS1015, pAS1016, pAS1017 and pAS1018 [encoding Fli-1(276-451) with the site-directed mutations A392D, V397D, F399D, V400D, M407K and V409D respectively] were constructed using fragments obtained using the same two-step PCR protocol and flanking primers, the template pAS303 and the mutagenic primers ADS699, ADS700, ADS701, ADS702, ADS703 and ADS704 respectively. PCR derived fragments were cleaved with NcoI and BamHI and inserted into the same sites in pAS305. pAS1018 includes the additional PCR introduced mutation T410N.
###end p 11
###begin title 12
Protein expression
###end title 12
###begin p 13
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 609 611 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
The synthesis of proteins by in vitro transcription and translation was carried out using either sequential transcription and translation or the coupled TNT' reticulocyte lysate system (Promega) according to the manufacturer's recommendations. Proteins were synthesised either directly from plasmid templates (see above) or from PCR products derived from these templates. The proteins Fli-1(276-391), Fli-1(276-411), Fli-1(276-431) and Fli-1(276-401) were made from templates synthesised by PCR using the primer pairs REV/ADS626, REV/ADS627, REV/ADS628, REV/ADS679 and pAS303 as a template. Newly synthesised 35S-labelled proteins were analysed by SDS-PAGE followed by visualisation and quantification by phosphorimage analysis (Fuji BAS-1500 phosphorimager and TINA 2.08e software). GST fusion proteins were purified as described previously (6). The purity and relative concentration of GST fusion proteins was determined following separation by SDS-PAGE.
###end p 13
###begin title 14
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro protein-protein interaction assays and western analysis
###end title 14
###begin p 15
###xml 25 35 25 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
###xml 336 347 <span type="species:ncbi:3704">horseradish</span>
Interactions between coreSRF(T196A) and in vitro translated Fli-1 derivatives were investigated using pulldown assays as previously described (6). Fli-1[VP16] fusion protein derivatives were detected by immunoblot analysis with an anti-VP16 mouse monoclonal antibody (kindly provided by P. O'Hare). Immune complexes were detected using horseradish peroxidase-conjugated secondary antibody followed by enhanced chemiluminescence (Amersham).
###end p 15
###begin title 16
Gel retardation assays
###end title 16
###begin p 17
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c24">24</xref>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c6">6</xref>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 207 217 207 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
###xml 254 262 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 278 288 278 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Gel retardation assays were performed with 32P-labelled probes as described previously (24). The c-fos SRE and the E74 binding sites have been described previously (6). Bacterially expressed coreSRF and coreSRF(T196A) were used except in Figure 3B where in vitro translated coreSRF(T196A) was used. All Fli-1 derivatives were synthesised by in vitro translation. Generally, reactions were normalised for reticulocyte lysate content. In peptide competition experiments, different concentrations (final concentrations ~10-500 microM) of peptides were pre-incubated with the proteins for 15 min at room temperature prior to the addition of DNA. Protein-DNA complexes were analysed on non-denaturing 5% polyacrylamide gels cast in 0.5x Tris-borate-EDTA and visualised by autoradiography and phosphorimaging.
###end p 17
###begin title 18
Cell culture transfection and reporter gene assays
###end title 18
###begin p 19
###xml 104 110 <span type="species:ncbi:9913">bovine</span>
NIH 3T3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) (Gibco BRL) and 25 mM glucose. Duplicate transfection experiments were carried out in six well plates using Superfect reagent according to the manufacturer's recommendations (Qiagen). For reporter gene assays, SRE-driven reporters were cotransfected alongside vectors encoding wild type and mutant Fli-1[VP16] fusion proteins. DNA concentrations were normalised with pcDNA3 vector.
###end p 19
###begin p 20
###xml 131 132 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 134 135 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 246 247 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 349 351 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c25">25</xref>
Transfected cells were incubated in Optimem' (Gibco BRL) for 24 h after transfection and lysed in 200 microl lysis buffer [100 mM K2PO4, pH 7.8, 0.2% Triton X-100, 0.5 mM dithiothreitol (DTT)]. Cell debris was removed by centrifugation at 14 000 g for 15 min at 4degreesC and the supernatant assayed for luciferase activity as described previously (25). Transfection efficiencies were standardised by normalising for the beta-galactosidase activity from co-transfected pCH110 plasmid (0.5 microg) (Pharmacia KB Biotechnology Inc.). beta-galactosidase activities were determined by the use of a chemiluminescent substrate in the Dual-light' reporter assay system (Tropix).
###end p 20
###begin title 21
Figure generation
###end title 21
###begin p 22
Figures were generated electronically from scanned images of autoradiographic images by using Picture Publisher (Micrografix) and Powerpoint 7.0 (Microsoft) software. Results are representative of the original autoradiographic images.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin title 24
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-fos</italic>
Ternary complex formation between Fli-1, SRF and the c-fos SRE
###end title 24
###begin title 25

###end title 25
###begin p 26
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egr</italic>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-fos</italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c20">20</xref>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-fos</italic>
###xml 1018 1021 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c26">26</xref>
###xml 798 807 <span type="species:ncbi:7955">zebrafish</span>
###xml 989 998 <span type="species:ncbi:7955">zebrafish</span>
###xml 1003 1008 <span type="species:ncbi:9606">human</span>
Both Fli-1 and the fusion protein EWS-Fli-1 have previously been shown to be capable of forming ternary complexes with SRF on SREs found in the egr-1 promoter. However, in contrast, only binding of EWS-Fli-1 to the c-fos SRE could be detected (20). In another study, binding of both Fli-1 and EWS-Fli-1 fusion proteins to the c-fos SRE could be detected (19). In order to confirm these results and probe for potential inhibitory domains in Fli-1, we tested the ability of full-length Fli-1 [Fli-1(1-451)] and an N-terminally truncated protein, Fli-1(220-451) (Fig. 1A), to form ternary complexes with SRF on the c-fos SRE. This N-terminal truncation endpoint was selected to correspond to the position of the Fli-1 moiety in the majority of EWS-Fli-1 fusion proteins. In these experiments, we used zebrafish Fli-1 as we reasoned that the critical interaction surfaces of Fli-1 should be evolutionarily conserved as the minimal DNA binding domains (and hence reciprocal binding surface) of zebrafish and human SRF (coreSRF) are 100% identical (26).
###end p 26
###begin p 27
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-fos</italic>
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
A ternary complex was observed between full-length Fli-1, SRF and the c-fos SRE (Fig. 1B, lane 1). Truncation of the N-terminal 220 amino acids of Fli-1 enhances its ability to form ternary complexes (Fig. 1B, lane 2). In contrast, neither of these proteins form complexes on the SRE in the absence of SRF (see Fig. 2; data not shown), implying that interactions with SRF are required for complex formation.
###end p 27
###begin p 28
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c8">8</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 159 162 <span type="species:ncbi:9860">Elk</span>
###xml 471 474 <span type="species:ncbi:9860">Elk</span>
We also tested the ability of these Fli-1 derivatives to form ternary complexes with an altered SRF protein which contains the point mutation T196A within the Elk-1 binding surface (8). In comparison to wild-type SRF, both Fli-1(1-451) and Fli-1(220-451) exhibit enhanced ternary complex forming ability with SRF(T196A) (Fig. 1B, lanes 3 and 4). This result further suggests that Fli-1 and SRF interact directly and that T196 defines part of the binding surface for both Elk-1 and Fli-1.
###end p 28
###begin p 29
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c8">8</xref>
###xml 1058 1061 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 47 50 <span type="species:ncbi:9860">Elk</span>
###xml 115 118 <span type="species:ncbi:9860">Elk</span>
###xml 243 246 <span type="species:ncbi:9860">Elk</span>
###xml 465 468 <span type="species:ncbi:9860">Elk</span>
###xml 726 729 <span type="species:ncbi:9860">Elk</span>
###xml 845 848 <span type="species:ncbi:9860">Elk</span>
###xml 1085 1088 <span type="species:ncbi:9860">Elk</span>
A peptide corresponding to the B-box region of Elk-1 (Fig. 1D) has previously been shown to disrupt the binding of Elk-1 to SRF-SRE complexes by acting as a competitor (7). In order to investigate whether the interaction surfaces of Fli-1 and Elk-1 on SRF overlap, we tested the ability of the B-box peptide to inhibit ternary complex formation by the high affinity SRF binding derivative of Fli-1, Fli-1(220-451). The B-box acts as a competitor for both Fli-1 and Elk-1 (compare Fig. 1E, lanes 2 and 3, and 8 and 9). In contrast, a non-specific peptide does not inhibit complex formation by either protein even at a 10-fold higher concentration (Fig. 1E, lanes 4-6 and 10-12). These results therefore indicate that Fli-1 and Elk-1 share similar binding surfaces on SRF. In support of this notion, in addition to T196A, several mutations on the Elk-1 binding surface of SRF have been shown to also affect ternary complex formation between Fli-1 and SRF (8; see Discussion). Collectively, these data show that Fli-1 forms ternary complexes with SRF and the c-fos SRE and that Fli-1 and Elk-1 bind to overlapping surfaces on SRF.
###end p 29
###begin title 30
Mapping the SRF-binding domain(s) on Fli-1
###end title 30
###begin p 31
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
A series of truncated Fli-1 proteins were created which contain the ETS DNA-binding domain but lack regions located either N- or C-terminally (Fig. 2A). Binding to the c-fos SRE could not be detected for any of these proteins in the absence of SRF (Fig. 2B). Moreover, binding by Fli-1(276-451) and Fli-1(276-372) could not be detected even in the presence of SRF (Fig. 2B, lanes 6 and 8). However, Fli-1(220-451) and to a lesser extent Fli-1(220-372) are able to form ternary complexes with SRF and the c-fos SRE (Fig. 2B, lanes 2 and 4). The region located N-terminal to the ETS-domain (amino acids 220-276) therefore appears to be sufficient to promote ternary complex formation although the region located C-terminal to the ETS-domain (amino acids 372-451) is required for maximal complex formation.
###end p 31
###begin p 32
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
The ability of the same series of truncated Fli-1 protein to form ternary complexes at the c-fos SRE with the mutant protein SRF(T196A) was also tested (Fig. 2C). Interestingly, in addition to Fli-1(220-451), the N-terminally truncated protein Fli-1(276-451) is able to form a ternary complex with SRF(T196A) albeit at a lower level (Fig. 2C, lane 3). Weak complex formation with Fli-1(220-372) could also be observed (data not shown). This result indicates that upon mutation of SRF, the region C-terminal to the ETS-domain (amino acids 372-451) becomes necessary and sufficient for promoting ternary complex formation. The N-terminal region (amino acids 220-276) is also required for maximal complex formation.
###end p 32
###begin p 33
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 433 443 433 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f2">2</xref>
###xml 20 23 <span type="species:ncbi:9860">Elk</span>
By analogy with the Elk-1/SRF paradigm, the simplest explanation of how ternary complex formation between Fli-1 and SRF is mediated, is by direct protein-protein interactions. Interactions between truncated Fli-1 proteins and GST-coreSRF were analysed by GST pull-down assays. Of the truncated Fli-1 derivatives, only specific binding of Fli-1(220-451) to wild- type SRF could be detected (data not shown). We therefore used GST-coreSRF(T196A) due to its higher affinity for Fli-1. In agreement with the gel retardation analysis (Fig. 2C), both Fli-1(220-451) and Fli-1(276-451) bind to SRF(T196A) (Fig. 2D, lanes 2 and 5). In contrast, neither the isolated ETS-domain Fli-1(276-372) nor the C-terminally truncated protein Fli-1(220-372) bind to SRF in this assay. These results demonstrate that Fli-1 and SRF interact directly and confirm that the region located C-terminal to the ETS-domain is the major binding surface with the mutant SRF protein SRF(T196A). In the case of interaction with wild-type SRF, both the N- and C-terminal regions of Fli-1 are required for interaction with SRF in the absence of DNA.
###end p 33
###begin p 34
Thus, it appears that Fli-1 contains two regions that interact with SRF. The region N-terminal to the ETS-domain is sufficient for interaction but requires the presence of the C-terminal region for maximal interaction. This C-terminal interaction motif is revealed by analysis of binding to the SRF(T196A) mutant where the reciprocal situation exists and the region N-terminal to the ETS-domain of Fli-1 is required for maximal binding.
###end p 34
###begin title 35
Analysis of the 'N-terminal' SRF binding motif in Fli-1
###end title 35
###begin p 36
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
###xml 835 836 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
One of the SBMs in Fli-1 is located between amino acids 220 and 276. In order to further define this interaction motif, a series of truncated Fli-1 proteins were produced in which the region located N-terminally to the ETS-domain was gradually deleted (Fig. 3A). Deletion to beyond amino acid 228 causes a reduction in binding of Fli-1 to SRF-SRE complexes (Fig. 3B, lanes 1-5), indicating that residues between positions 220 and 229 play critical roles in this process. However, all the deleted proteins bind efficiently to the E74 binding site in the absence of SRF, indicating that their DNA binding activity is not compromised (Fig. 3B, lanes 11-15). Furthermore, with the exception of Fli-1(266-451), all these proteins efficiently form complexes with SRF(T196A), indicating that their C-terminal region is still functional (Fig. 3B, lanes 6-10). The reduction in binding observed with Fli-1(266-451) indicates that amino acids 256-265 are required in conjunction with the C-terminal region for maximal binding to SRF(T196A) (see Discussion).
###end p 36
###begin p 37
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 908 909 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 173 176 <span type="species:ncbi:9860">Elk</span>
Site-directed mutagenesis was used in order to identify amino acids that are important in the binding process whilst retaining the integrity of the protein. By analogy with Elk-1 (7), it was anticipated that hydrophobic residues might play a major role in binding to SRF. Hydrophobic amino acids located before and after the deletion end point in Fli-1 (229-451) were therefore altered to charged residues to disrupt potential hydrophobic interaction surfaces (Fig. 4B). The amino acids selected exhibit a high degree of evolutionary conservation (Fig. 4A). The mutant proteins Fli-1(220-451) Y222D, A224D and V225E all exhibit reduced ternary complex forming ability (Fig. 4C, lanes 3-5). However, binding by the mutated Fli-1(220-451) W230R is not decreased (Fig. 4C, lane 6). All the mutant Fli-1 proteins bind to the E74 site efficiently, indicating that their DNA binding activity is not impaired (Fig. 4C, lanes 7-12). These data are therefore consistent with the deletion analysis and identify residues Y222, A224 and V225 within the region 220-228 as important determinants within the N-terminal SRF interaction motif.
###end p 37
###begin title 38
Analysis of the 'C-terminal' SRF binding motif in Fli-1
###end title 38
###begin p 39
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f5">5</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f5">5</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f5">5</xref>
###xml 1045 1046 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f5">5</xref>
###xml 1507 1508 1507 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
###xml 1630 1631 1630 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
###xml 1793 1794 1793 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
###xml 1889 1890 1889 1890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
A second SRF-binding motif in Fli-1 is located between amino acids 373 and 451. In order to further define this interaction motif, a series of truncated Fli-1 proteins were produced in which the region located C-terminally to the ETS-domain was gradually deleted in the context of the truncated Fli-1 derivative, Fli-1(276-451) (Fig. 5A). In this case, binding to the mutant protein SRF(T196A) was analysed. Deletion to beyond amino acid 411 results in a reduction of binding of Fli-1(276-451) to SRF-SRE complexes (Fig. 5B, lanes 1-5), indicating that residues between positions 392 and 411 play a critical role in this process. However, all the deleted proteins bind efficiently to the E74 site in absence of SRF, indicating that their DNA binding activity is not compromised (Fig. 5B, lanes 6-10). An additional deletion construct, Fli-1(276-401), was constructed to further define the SRF interaction motif. In comparison to Fli-1(276-451), this protein still retains the ability to bind to SRF-SRE complexes but with reduced affinity (Fig. 5C, lanes 1 and 3). This indicates that whilst the region encompassing amino acids 402-411 contains amino acids required for maximal interactions with SRF, residues located between amino acids 392 and 401 play important roles in mediating these interactions. Point mutations were introduced before and after amino acid 401 to identify residues that play an important role in binding to SRF. Again, conserved hydrophobic residues were targeted for mutation (Fig. 6A and B). Ternary complex formation by the mutant proteins Fli-1(276-451) A392D, V397D and F399D was not detectable (Fig. 6C, lanes 1-3). However, the mutant derivatives V400D, M407K and V409D still form complexes with comparable or greater efficiency than the wild-type protein (Fig. 6C, lanes 4-8). All the mutant proteins efficiently form binary complexes on the E74 site (Fig. 6C, lanes 9-16).
###end p 39
###begin p 40
Collectively, these data therefore indicate that residues A392, V397 and F399 within the region 392-401 are important determinants within the C-terminal SRF interaction motif although additional residues between amino acids 402 and 411 are required for maximal binding.
###end p 40
###begin title 41
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Interactions between Fli-1 and SRF are required for recruitment of Fli-1 into ternary complexes in vivo
###end title 41
###begin p 42
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
To investigate the importance of the SBMs in vivo, mutations were first introduced into Fli-1 in the context of the full-length protein and the truncated version, Fli-1(220-451) (Fig. 7A). Consistent with the effects of the individual mutations, the introduction of the two mutations A224D/V225E into Fli-1 abrogates its ability to form ternary complexes with SRF and the c-fos SRE (Fig. 7B, lane 2).
###end p 42
###begin p 43
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 426 433 426 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c27">27</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 336 339 <span type="species:ncbi:9860">Elk</span>
###xml 391 394 <span type="species:ncbi:9860">Elk</span>
The mutations A224D/V225E were also introduced into a Fli-1 fusion protein composed of Fli-1 amino acids 1-451 fused to the VP16 transactivation domain (Fig. 1D). This VP16 fusion protein represents a constitutively active version of Fli-1 that does not require activation by signalling pathways or co-regulatory proteins. An analogous Elk-1-VP16 fusion protein has been used to demonstrate Elk-1 recruitment to the c-fos SRE in vivo (7,27). The expression of wild-type Fli-1[VP16] and Fli-1[VP16](A224D/V225E) was monitored by western blotting. Both proteins were expressed to similar extents with Fli-1[VP16](A224D/V225E) being expressed to a slightly higher level (Fig. 1C).
###end p 43
###begin p 44
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 987 988 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 1352 1353 1352 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 1453 1454 1453 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 321 324 <span type="species:ncbi:9860">Elk</span>
The ability of the wild-type and mutant Fli-1 proteins to be recruited to the c-fos SRE in vivo was determined by transient transfection of the two Fli-1 derivatives with a c-fos SRE-luciferase reporter plasmid. Wild-type Fli-1[VP16] activates the c-fos SRE in a dose-dependent manner (Fig. 7D) in an analogous manner to Elk-1[VP16] (7; data not shown). However, no significant activation of the c-fos SRE could be observed by the Fli-1[VP16](A224D/V225E) mutant protein (Fig. 7D). In order to verify that the mutations into Fli-1 do not abrogate the ability of Fli-1[VP16](A224D/V225E) to activate transcription rather than its ability to interact with SRF, this protein was tested for its ability to activate an E74-CAT reporter. This reporter construct can be bound and activated by ETS-domain proteins in the absence of coregulatory partners (7). Both wild-type and mutant Fli-1 proteins can activate the E74-CAT reporter gene, albeit at a reduced level for the mutant protein (Fig. 7D, 8-fold and 4-fold respectively). At the same concentration of transfected DNA, no significant activation of the SRE is observed, demonstrating the specificity of the mutations in blocking activation in complexes with SRF. At higher concentrations of Fli-1 (A224D/V225E), transcriptional squelching was observed on both the SRE and E74 reporter constructs (Fig. 7D, data not shown), most likely reflecting the higher expression level of this mutant protein (Fig. 7C).
###end p 44
###begin p 45
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 182 185 <span type="species:ncbi:9860">Elk</span>
Together, these data indicate that Fli-1 can be recruited to the c-fos SRE in vivo and that disruption of the N-terminal SRF-interaction motif abrogates this recruitment. Thus, like Elk-1, SAP-1 and SAP-2, Fli-1 can be considered a ternary complex interaction partner for SRF at SREs.
###end p 45
###begin title 46
DISCUSSION
###end title 46
###begin p 47
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c28">28</xref>
###xml 445 447 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c29">29</xref>
###xml 557 558 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c1">1</xref>
###xml 559 560 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c3">3</xref>
###xml 771 772 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f8">8</xref>
###xml 1021 1024 1017 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1029 1036 1025 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
It is becoming evident that multicomponent transcription complexes play a major role in regulating the expression of eukaryotic genes. In combination with molecular biological approaches, recent structural studies have elucidated the mechanisms of how several such complexes form (reviewed in 28). One such study demonstrated how the ankyrin repeats of GABP2 mediate interactions with the DNA-binding domain of the ETS-domain protein GABPalpha (29). Indeed, many ETS-domain proteins have been shown to interact with other transcription factors (reviewed in 1-3). In this study we have investigated how Fli-1 interacts with the MADS-box transcription factor SRF. Two SBMs have been identified, which are located on either side of the ETS DNA-binding domain of Fli-1 (Fig. 8A). Important amino acids within these motifs have been identified by using site-directed mutagenesis. By investigating Fli-1 proteins with mutations in SBM1, the importance of the interactions between Fli-1 and SRF in recruitment of Fli-1 to the c-fos SRE in vivo have been demonstrated.
###end p 47
###begin p 48
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egr</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c20">20</xref>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c15">15</xref>
###xml 651 660 <span type="species:ncbi:7955">zebrafish</span>
It has been previously shown that complexes can be formed between mammalian Fli-1 and SRF complexes at the c-fos (19) and egr-1 (20) SREs. In the latter study, Fli-1-SRF complexes could not be detected at the c-fos SRE, possibly due to the sensitivity of the assay system. However, deletion of the N-terminal region of Fli-1, either artificially or in EWS-Fli-1 fusion proteins, results in an enhancement of the ability of Fli-1 to form ternary Fli-1-SRF-SRE complexes (19). These observations suggest the presence of an inhibitory region at the N-terminus of Fli-1. Indeed, our results support this conclusion, as truncation of the N-terminus of the zebrafish Fli-1 homologue raises its affinity for both ternary complex formation (Fig. 1) and its ability to bind autonomously to the high affinity E74 site (15).
###end p 48
###begin p 49
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c10">10</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
Here, we have mapped the important parts of the SBMs in Fli-1 to amino acids 220-228 (N-terminal to the ETS-domain) and amino acids 392-401 (C-terminal to the ETS-domain). Significantly, the N-terminal limit of SBM, corresponds almost exactly to the N-terminal end of the Fli-1 moiety contained in the most commonly found EWS-Fli-1 fusion proteins (10). Indeed, 94% of EWS-Fli-1 proteins contain SBM1. Furthermore, both SBM1 and SBM2 are highly conserved amongst vertebrate Fli-1 homologues (Figs 4A and 6A), further implying a functional importance for these motifs.
###end p 49
###begin p 50
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f4">4</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f6">6</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c20">20</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c7">7</xref>
###xml 851 852 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c8">8</xref>
###xml 99 102 <span type="species:ncbi:9860">Elk</span>
###xml 273 276 <span type="species:ncbi:9860">Elk</span>
###xml 384 387 <span type="species:ncbi:9860">Elk</span>
###xml 499 502 <span type="species:ncbi:9860">Elk</span>
###xml 631 634 <span type="species:ncbi:9860">Elk</span>
###xml 952 955 <span type="species:ncbi:9860">Elk</span>
###xml 1136 1139 <span type="species:ncbi:9860">Elk</span>
###xml 1238 1241 <span type="species:ncbi:9860">Elk</span>
The mechanism of interaction of Fli-1 with SRF shows several key differences to the interaction of Elk-1 with SRF. Although hydrophobic residues appear to be important in both cases, neither SBM1 nor SBM2 show any significant homology with the SRF binding motif (B-box) in Elk-1 (compare Figs 1D, 4B and 6B). Moreover, the SBM1 maps to outside a region suggested to be related to the Elk-1 B-box (20). However, as no proline residues are found within SBM1 and SBM2, it is possible that as shown for Elk-1 (7), these motifs might be able to adopt an alpha-helical conformation for binding to SRF. The binding surfaces for Fli-1 and Elk-1 on SRF also appear to differ significantly. Although competition experiments clearly demonstrate an overlap in binding surfaces, mutagenic studies indicate that distinct residues play important roles in each case (8). For example, whilst the mutation V194E in SRF virtually abolishes ternary complex formation with Elk-1, the binding of Fli-1 is still readily detectable. A similar scenario is observed with the mutation T196A which enhances interactions with Fli-1 whilst leaving interactions with Elk-1 unaffected. Other mutations such as T196K result in reduced complex formation by both Fli-1 and Elk-1. Thus, whilst the binding surfaces overlap, further detailed mutagenesis is required to define the binding surface(s) on SRF to which Fli-1 binds.
###end p 50
###begin p 51
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f7">7</xref>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egr-1</italic>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c20">20</xref>
###xml 867 870 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f1">1</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c19">19</xref>
###xml 1149 1156 1149 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1209 1210 1209 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c5">5</xref>
###xml 557 560 <span type="species:ncbi:9860">Elk</span>
###xml 1178 1181 <span type="species:ncbi:9860">Elk</span>
The in vivo significance of Fli-1 interactions with SRF is currently unclear. However, in this study we provide the first evidence that Fli-1 can be recruited to the c-fos SRE in vivo and that interactions with SRF are critical in this process (Fig. 7). It should be emphasised that we do not envisage SRF and Fli-1 existing in non-DNA bound complexes in vivo and there is currently no evidence to support such a notion. It is likely that protein-DNA contacts by Fli-1 are essential for its recruitment into complexes with SRF in an analogous manner to the Elk-1-SRF complex. Indeed, higher affinity Fli-1-SRF complexes are likely to occur on other sites that contain more optimal ets binding motifs such as in the egr-1 promoter (20). Furthermore, due to the loss of the inhibitory N-terminal end of Fli-1, EWS-Fli-1 chimeras form higher affinity complexes at the c-fos and probably other SREs (Fig. 1; 19). Overexpression of Fli-1 as observed in erythroleukaemias, is also likely to drive the formation of ternary complexes with SRF. Finally, it is currently unclear whether complex formation by Fli-1 is regulated by signal transduction pathways in vivo as observed with the Elk-1-SRF complex (reviewed in 5) but such a mechanism could also lead to enhanced ternary complex formation.
###end p 51
###begin p 52
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f8">8</xref>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd142f3">3</xref>
###xml 911 913 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c30">30</xref>
###xml 932 934 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd142c31">31</xref>
###xml 841 844 <span type="species:ncbi:9860">Elk</span>
Several models can be envisaged for how Fli-1 interacts with SRF at the c-fos SRE. One of these is depicted in Figure 8B, in which Fli-1 makes protein-DNA contacts with the ets motif in the SRE via its ETS DNA-binding domain and makes protein-protein contacts with SRF via SBM1 and SBM2. In this model, SBM1 and SBM2 bind different SRF monomers but it is equally likely that the two motifs bind to the same SRF monomer. Furthermore, additional complexities are suggested by the observation that the region immediately N-terminal to the ETS-domain (amino acids 256-266) is required for maximal binding by SBM2 (Fig. 3), suggesting that these regions co-operate in some manner. In summary, therefore, our data allow a model to be derived for how Fli-1 interacts with SRF. The mechanism of complex assembly shows several key differences to the Elk-1-SRF complex. As other transcription factors including NFkappaB (30) and SPIN/TFII-I (31) have also been shown to bind to SRF, it will also be interesting to determine how these diverse proteins interact with SRF. Transcription factor complexes containing SRF therefore serve as a useful model to further our understanding of how multicomponent transcription factor complexes are assembled.
###end p 52
###begin title 53
Figures and Tables
###end title 53
###begin p 54
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 270 271 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 442 445 442 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 689 690 689 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 732 735 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 883 884 883 884 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1102 1103 1102 1103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1234 1237 1234 1237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 1248 1251 1248 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1502 1503 1502 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 1540 1541 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 777 780 <span type="species:ncbi:9860">Elk</span>
###xml 941 944 <span type="species:ncbi:9860">Elk</span>
###xml 976 979 <span type="species:ncbi:9860">Elk</span>
###xml 1193 1196 <span type="species:ncbi:9860">Elk</span>
###xml 1558 1561 <span type="species:ncbi:9860">Elk</span>
 Fli-1 forms a ternary complex with wild-type SRF and mutant SRF (T196A) at the c-fos SRE. (A) Diagrammatic representation of full-length Fli-1 [Fli-1(1-451)] and the N-terminally truncated derivative Fli-1 (220-451). The ETS DNA-binding domain is shown as a grey box. (B) Gel retardation analysis of ternary complexes formed between the indicated Fli-1 derivatives, wild-type (lanes 1 and 2) and the T196A mutant form (lanes 3 and 4) of coreSRF and the c-fos SRE. Equal molar amounts of each Fli-1 construct were used in all the binding reactions. The location of the ternary (30) Fli-1-SRF-SRE and binary (20) SRF-SRE complexes are indicated by brackets and an open arrow respectively. (C) Structure of SRF (black) bound to the c-fos SRE (grey) (32). Residues comprising the Elk-1 binding surface are shown in white (8). The location of T196 within this surface is shown in grey. (D) Diagrammatic representation of the domain structure of Elk-1 and the truncated derivative Elk-1(1-168). The sequence of the B-box region used to derive peptides for competition assays as shown below these diagrams. (E) Gel retardation analysis of ternary complex formation by Fli-1(220-451) (lanes 1-6) and Elk-1(1-168) (lanes 7-12), wild-type coreSRF and the c-fos SRE in the presence of increasing amounts of competitor B-box peptide (120 pmol, lanes 1 and 8; 600 pmol, lanes 2 and 9) or a non-specific peptide (12 pmol, lanes 4 and 10; 600 pmol, lanes 5 and 11; 6 nmol, lanes 6 and 12). The locations of binary (20, open arrows) SRF-SRE and ternary (30, closed arrows) Elk-1/Fli-1-SRF-SRE complexes are indicated.
###end p 54
###begin p 55
###xml 54 55 54 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 183 184 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 400 401 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 438 439 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 496 497 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 596 606 596 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 666 667 666 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 709 711 709 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 766 776 766 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
 Identification of two SRF binding domains on Fli-1. (A) Diagrammatic representation of truncated Fli-1 proteins. Numbers represent the first and last amino acids in each construct. (B) Gel retardation analysis of binary and ternary complex formation by the indicated Fli-1 derivatives in the absence (lanes 1, 3, 5 and 7) and presence (lanes 2, 4, 6 and 8) of coreSRF. The locations of the binary (20, open arrows) SRF-SRE and ternary (30, closed arrows) Fli-1-SRF-SRE complexes are indicated. (C) Gel retardation analysis of ternary complex formation by the indicated Fli-1 derivatives and coreSRF(T196A). The identities of the complexes are indicates as in (B). (D) GST pull-down analysis of the indicated 35S-labelled Fli-1 derivatives and either GST or GST coreSRF(T196A). Ten percent of the input proteins is shown in lanes 1, 4, 7 and 10.
###end p 55
###begin p 56
###xml 47 48 47 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 324 334 324 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 459 462 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
 Mapping of the N-terminal SRF binding motif. (A) Diagrammatic representation of N-terminally truncated Fli-1 proteins. Numbers represent the first and last amino acids in each construct. (B) Gel retardation analysis of ternary complex formation by the indicated Fli-1 derivatives, wild-type coreSRF (lanes 1-5), mutant coreSRF(T196A) (lanes 6-10) and the c-fos SRE. Binary complex formation by the same Fli-1 proteins with the E74 site in the absence of coreSRF is shown in lanes 11-15.
###end p 56
###begin p 57
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 372 373 372 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 445 446 445 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 632 635 632 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 746 747 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 784 785 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 202 211 <span type="species:ncbi:7955">zebrafish</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 427 436 <span type="species:ncbi:7955">zebrafish</span>
 Identification of important residues within the N-terminal SRF interaction motif. (A) Alignment of the sequences surrounding the truncation endpoint in Fli-1(229-451) (indicated by a black arrow) from zebrafish, xenopus, mouse and human homologues. Residues conserved in three or more species are shaded grey, and fully conserved amino acids are indicated by asterisks. (B) Location and identity of the amino acids mutated in zebrafish Fli-1. (C) Gel retardation analysis of complex formation by the indicated truncated and mutant Fli-1 derivatives in the presence of coreSRF and the c-fos SRE (lanes 1-6) or in the absence of coreSRF on the E74 site (lanes 7-12). The locations of the ternary Fli-1-SRF-SRE (30, closed arrow), binary SRF-SRE (20, open arrow) and binary Fli-1-E74 (20, grey arrow) complexes are indicated.
###end p 57
###begin p 58
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 181 182 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 285 295 285 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 443 446 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
 Mapping of the C-terminal SBM. (A) Diagrammatic representation of C-terminally truncated Fli-1 proteins. Numbers represent the first and last amino acids in each construct. (B and C) Gel retardation analysis of ternary complex formation by the indicated Fli-1 derivatives, mutant coreSRF(T196A) [(B), lanes 1-5 and (C), lanes 1-3] and the c-fos SRE. Binary complex formation by the same Fli-1 proteins with the E74 site in the absence of coreSRF is shown in (B), lanes 6-10.
###end p 58
###begin p 59
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 558 559 558 559 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 686 696 686 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF(T196A)</sup>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 831 832 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 866 867 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 904 905 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 237 246 <span type="species:ncbi:7955">zebrafish</span>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 462 471 <span type="species:ncbi:7955">zebrafish</span>
 Identification of important residues within the C-terminal SRF interaction motif. (A) Alignment of the sequences surrounding the truncation endpoints in Fli-1(276-391), Fli-1(276-401) and Fli-1(276-411) (indicated by black arrows) from zebrafish, xenopus, mouse and human homologues. Residues conserved in three or more species are shaded grey, and fully conserved amino acids are indicated by asterisks. (B) Location and identity of the amino acids mutated in zebrafish Fli-1. A summary of the results of the gel retardation assays is shown on the right. (C) Gel retardation analysis of complex formation by the indicated truncated and mutant Fli-1 derivatives in the presence of coreSRF(T196A) and the c-fos SRE (lanes 1-8) or in the absence of coreSRF on the E74 site (lanes 9-16). The locations of the ternary Fli-1-SRF-SRE (30, closed arrow), binary SRF-SRE (20, open arrow) and binary Fli-1-E74 (20, grey arrow) complexes are indicated.
###end p 59
###begin p 60
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 199 200 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SRF</sup>
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 420 421 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 469 470 469 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 820 821 808 809 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
 Mutations in the N-terminal SBM reduce Fli-1 recruitment to the c-fos SRE in vitro and in vivo. (A) Diagrammatic representation of wild-type and mutant, full-length and truncated Fli-1 constructs. (B) Gel retardation analysis of ternary complex formation by wild-type and A224D/V225E mutant Fli-1(220-451), wild-type coreSRF and the c-fos SRE. The locations of the ternary (30, closed arrow) Fli-1-SRF-SRE and binary (20, open arrow) SRF-SRE complexes are indicated. (C) Western analysis of the expression of wild-type Fli-1(1-451)[VP16] and mutant Fli-1(1-451)[VP16](A224D/V225E) in NIH 3T3 cells. Lysates are analysed that contain increasing amounts of each Fli-expression vector (0.25 microg, lanes 1 and 4; 1 microg, lanes 2 and 5; 5 microg, lanes 3 and 6) and expression was detected using an anti-VP16 antibody. (D) Activation of SRE-luciferase (left) and E74-CAT (right) reporters by wild-type and mutant Fli-1-VP16 fusion proteins. The SRE-luciferase reporter construct (50 ng) was transfected into NIH 3T3 cells either alone or with increasing amounts of wild-type and mutant A224D/V225E Fli-1(1-451)[VP16] (0.5 and 1 microg) and a beta-galactosidase expression vector. For the E74-CAT transfections, 1 microg E74-CAT and 0.5 microg of wild-type or mutant Fli-1 were cotransfected.
###end p 60
###begin p 61
###xml 32 33 32 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 257 258 257 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 562 570 <span type="species:ncbi:301928">ellipses</span>
 Model of the Fli-SRF complex. (A) Diagrammatic representation of Fli-1 showing the locations of the two SBMs relative to the ETS DNA-binding domain. The numbers of the amino acids mapped to the N- and C-terminal extents of these two motifs are indicated. (B) Model of the structure of the Fli-1-SRF complex. In this model, the two SBMs contact different SRF monomers although two contact points on the same monomer is also plausible (see Discussion). The ETS-domain and SBMs of Fli-1 are shown in dark grey whereas each SRF monomer is represented by light grey ellipses. DNA is represented by an extended black rectangle.
###end p 61
###begin title 62
ACKNOWLEDGEMENTS
###end title 62
###begin p 63
###xml 199 206 <span type="species:ncbi:9606">Patient</span>
We would like to thank Margaret Bell for excellent technical assistance and Lynne Smith for secretarial assistance. We would also like to thank Bob Liddell for DNA sequencing and Adam Rodaway, Roger Patient, Peter O'Hare and Richard Treisman for reagents. We are grateful to Alan Hair, Paul Shore and Shen-Hsi Yang for comments on the manuscript and members of our laboratory for helpful discussions. This work was supported by the Wellcome Trust and the UK Cancer Research Campaign [CRC]. A.D.S. is a Research Fellow of the Lister Institute of Preventative Medicine.
###end p 63
###begin title 64
REFERENCES
###end title 64

